Kiora Pharmaceuticals's total assets for Q2 2026 were $23.78M, an increase of 12.01% from the previous quarter. DE:7EY total liabilities were $6.92M for the fiscal quarter, a -5.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.